-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aptiv, Lowers Price Target to $60

Benzinga·10/09/2026 14:08:08
Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $65 to $60.